Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McMaster University

$27,000.00

Characterizing the Immunosuppressive Mechanisms of Glioblastoma Upon Gamma Delta T Cells

FY 2025-26

Summary
Glioblastoma is the most aggressive brain cancer, with a median survival of only 15 months. Current therapies often fail because glioblastoma tumours suppress the immune system, preventing immune cells from attacking the cancer. Gamma-delta T cells are specialized immune cells showing promise as off-the-shelf cell therapy—manufactured in advance for multiple patients without personalization. When engineered with tumour-targeting receptors, they effectively recognize and kill cancer cells. However, preliminary research revealed a critical problem: glioblastoma cells rapidly shut down engineered gamma-delta T cells within four hours of contact, severely limiting anti-tumour activity. Understanding this mechanism is essential for developing effective treatments. This project will investigate how glioblastoma cells suppress gamma-delta T cells using single-nuclei RNA sequencing to analyze transcriptomic activity of both cell types during interaction. This technology examines thousands of individual cells simultaneously, providing an unbiased, comprehensive view of cellular changes. Preliminary experiments show this suppression requires direct cell-to-cell contact and involves changes in cellular metabolism and stress responses. Different glioblastoma cell lines suppress T cells through different mechanisms, suggesting multiple pathways are involved. By identifying specific molecules and pathways responsible for immune suppression, this research will reveal new therapeutic targets. The findings will guide strategies to protect gamma-delta T cells from suppression, improving their effectiveness as cancer immunotherapies. This work has broader implications for understanding how tumours evade immune responses and could inform treatments for other cancers beyond glioblastoma.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573172
Name
Naqvi Hamza
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing the Immunosuppressive Mechanisms of Glioblastoma Upon Gamma Delta T Cells
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Bioinformatics; Cancer Immunotherapy; Cellular Metabolism; Gamma-Delta T Cells; Glioblastoma; Immunosuppression; Single-Cell Rna Sequencing; Synthetic Antigen Receptors; Transcriptomics; Tumor-Immune Interactions
Abstract
Glioblastoma is the most aggressive brain cancer, with a median survival of only 15 months. Current therapies often fail because glioblastoma tumours suppress the immune system, preventing immune cells from attacking the cancer. Gamma-delta T cells are specialized immune cells showing promise as off-the-shelf cell therapy—manufactured in advance for multiple patients without personalization. When engineered with tumour-targeting receptors, they effectively recognize and kill cancer cells. However, preliminary research revealed a critical problem: glioblastoma cells rapidly shut down engineered gamma-delta T cells within four hours of contact, severely limiting anti-tumour activity. Understanding this mechanism is essential for developing effective treatments. This project will investigate how glioblastoma cells suppress gamma-delta T cells using single-nuclei RNA sequencing to analyze transcriptomic activity of both cell types during interaction. This technology examines thousands of individual cells simultaneously, providing an unbiased, comprehensive view of cellular changes. Preliminary experiments show this suppression requires direct cell-to-cell contact and involves changes in cellular metabolism and stress responses. Different glioblastoma cell lines suppress T cells through different mechanisms, suggesting multiple pathways are involved. By identifying specific molecules and pathways responsible for immune suppression, this research will reveal new therapeutic targets. The findings will guide strategies to protect gamma-delta T cells from suppression, improving their effectiveness as cancer immunotherapies. This work has broader implications for understanding how tumours evade immune responses and could inform treatments for other cancers beyond glioblastoma.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Naqvi, Hamza
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~